drug
poliomyelitis [strains (Mahoney + MEF-1 + Saukett)] (trivalent) vaccine
Marketedupdated 5mo agoby Sanofi Pasteur Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying poliomyelitis [strains (Mahoney + MEF-1 + Saukett)] (trivalent) vaccine
- phase1Safety and Immunogenicity of a Recombinant Poliomyelitis Vaccine (rPV) in Comparison With IPOL Vaccine in Healthy Adults
- N/ASafety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
- N/AZero Fluoroscopy Voltage Guided vs. Linear CTI Ablation
- —MDR - PMCF Study for RingLoc Bipolar Acetabular Cup and Endo II Femoral Heads
- —Observational Study to Evaluate Long-Term Outcome in Hip Hemiarthroplasty
- phase2Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)
- —Personalized Therapy Study - Attain Stability Quad Post-Approval Study
- N/AA Feasibility Study Evaluating the Performance of Focused Multipolar Stimulation and Sound Coding in Adults.
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that